WisdomTree Global ex-U.S. Quality Growth Fund DNL
40.93 USD -2.86 (-6.53%)
At closeNov 5, 2026, 7:30 PM EST
40.93 0.00 0.00%
After hours · Nov 5, 7:30 PM ET
40.93 Day range 42.67
38.87 52-week range 47.46
- YTD
- -0.70%
- 1 year
- +0.47%
- Market cap
- 468.58M
- EPS (ttm)
- 2.24
- P/E ratio
- 18.31
- YTD return
- -0.70%
- 1-year return
- +0.47%
- Volume
- 42.37K
- Avg volume
- 16.17K
- Open
- 42.67
- Previous close
- 43.79
- Day's range
- 40.93 – 42.67
- 52-week range
- 38.87 – 47.46
2Y +3.57 (+9.56%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 37.56
- 200-day average
- 38.59
About WisdomTree Global ex-U.S. Quality Growth Fund
Under normal circumstances, at least 95% of the fund's total assets (exclusive of collateral held from securities lending) will be invested in constituent securities of the index and investments that have economic characteristics that are substantially identical to the economic characteristics of such constituent securities. The index is a fundamentally weighted index that consists of dividend-paying global ex-U.S. common stocks with growth characteristics. The fund is non-diversified.
News
Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights 
What's Going On With Shopify Stock Tuesday? 
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics' Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II) 
Denali: Maintaining Strong Buy Based On DNL126 Expansion As MPS IIIA Treatment 
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? 
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? 
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now? 
DNL: Lagging Its Peers For A While 
Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program 
Is WisdomTree Global ex-U.S. Quality Dividend Growth ETF (DNL) a Strong ETF Right Now?
Your note
Sign in to keep a note on DNL — it syncs with the Stock Master app.